Lakefront Biotherapeutics N.V.

LKFT | NASDAQ

$32.02

-$0.26 (-0.81%)

Nov 2, 2026, 12:36 PM ET · Market open

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021
PE Ratio	5.71	23.71	11.65	-12.48	-26.35
PEG Ratio	0.02	-0.36	-0.06	-0.16	n/a
PS Ratio	1.65	6.37	10.28	11.28	11.58
PB Ratio	0.57	n/a	n/a	n/a	n/a
P/FCF Ratio	-6.76	n/a	n/a	n/a	n/a
P/OCF Ratio	-7.12	n/a	n/a	n/a	n/a
OCF/S Ratio	-23.15	n/a	n/a	n/a	n/a
Debt / Equity Ratio	0	n/a	n/a	n/a	n/a
Quick Ratio	20	n/a	n/a	n/a	n/a
Current Ratio	20.15	n/a	n/a	n/a	n/a
Asset Turnover	0.33	n/a	n/a	n/a	n/a
Interest Coverage	226.16	-206.74	-49.87	-14.32	-19.66
Return on Equity	9.92%	n/a	n/a	n/a	n/a
Return on Assets	9.42%	n/a	n/a	n/a	n/a
Return on Invested Capital	15.40%	n/a	n/a	n/a	n/a
Dividend Yield	n/a	n/a	n/a	n/a	n/a
Payout Ratio	n/a	n/a	n/a	n/a	n/a
FCF Payout Ratio	n/a	n/a	n/a	n/a	n/a
Gross Profit Margin	97.33%	87.35%	100%	100%	-36.74%
Net Profit Margin	28.85%	26.88%	88.31%	-90.36%	-44.04%
Pretax Profit Margin	27.05%	-1.12%	2.35%	-29.37%	-50.94%
Operating Profit Margin	45.08%	-68.33%	-36.82%	-54.32%	-73.20%
FCF Margin	-24.39%	n/a	n/a	n/a	n/a
EBITDA Margin	32.27%	15.72%	21.29%	1.60%	-69.65%